Blockade of postocclusive renal vasoconstriction by an angiotensin II antagonists: evidence for an angiotensin-adenosine interaction.
D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000494:pharmacology*; D000241:Adenosine / Q000494:pharmacology* / Q000502:physiology; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000502:physiology; D000818:Animals; D004285:Dogs; D007668:Kidney / Q000098:blood supply*; D009638:Norepinephrine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D012078:Renal Artery Obstruction / Q000503:physiopathology*; D014661:Vasoconstriction / Q000187:drug effects*
D000804:Angiotensin II; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D000241:Adenosine; D009638:Norepinephrine